Employment Agreement - Emergent BioSolutions Inc. and Steven Chatfield
July 11, 2006
|
||
|
Emergent BioSolutions Inc. | |
|
300 Professional Drive, Suite 250 | |
|
Gaithersburg. MD 20879 | |
|
||
|
t 301 944 0290 | |
|
f 301 944 0173 | |
|
www.emergentbiosolutions.com | |
Dr. Steven Chatfield
|
||
31, Kenwood Drive
|
||
Beckingham, Kent
|
||
UNITED KINGDOM
|
||
|
||
RE: Role of Chief Scientific Officer
|
1. | You will spend one week per month in the US and the Maryland corporate offices attending to the duties related to performing your responsibilities as CSO of Emergent BioSolutions Inc. These duties and responsibilities are set forth in Attachment 1. | ||
2. | You will be flexible regarding travel to the US in excess of one week a month on an as-needed basis. | ||
3. | You will not renew your lease for your Gaithersburg apartment which expires on August 31, 2006 and will no longer receive the monthly $1,900.00 stipend. | ||
4. | While you are in the US or elsewhere in the world performing your duties, you will submit business expenses (e.g., hotel, car rental, business meals, etc.) in accordance with the Company's reimbursement policies as they may exist from time to time. |
1. | You are not required to relocate your residence to the US. | ||
2. | You will not be required to repay the first portion of the relocation stipend in the amount of US$15,000. | ||
3. | You will no longer receive a per diem payment of $100.00 for each day that you are in the US on business in fulfilling your CSO responsibilities. | ||
4. | You have received reimbursement from the Company of all amounts related to the US$3,000 payment referenced in the penultimate paragraph on page 2 of the September 16, 2005, Letter Agreement. |
/s/ S. N. Chatfield
|
||
Steven N. Chatfield, Ph.D.
|
1. | Present at scientific conferences and meetings | ||
2. | Advise CEO, EMC, and Board of Directors on scientific matters and issues | ||
3. | Assist Business Development in identifying opportunities and assessing them as they arise | ||
4. | Support corporate interactions in connection with financing and acquisition activities | ||
5. | Assist scientific advisory panel in achieving their agreed upon objectives | ||
6. | Assist in patent prosecution matters and other actions to advance intellectual property estate of the Company |